首页> 外文期刊>Patient Preference and Adherence >Patient-reported adverse drug reactions and their influence on adherence and quality of life of chronic myeloid leukemia patients on per oral tyrosine kinase inhibitor treatment
【24h】

Patient-reported adverse drug reactions and their influence on adherence and quality of life of chronic myeloid leukemia patients on per oral tyrosine kinase inhibitor treatment

机译:口服酪氨酸激酶抑制剂治疗患者报告的药物不良反应及其对慢性粒细胞白血病患者依从性和生活质量的影响

获取原文
           

摘要

Purpose: To evaluate adverse drug reactions (ADRs) experienced by chronic myeloid leukemia (CML) patients during per oral tyrosine kinase inhibitor (TKI) treatment and correlation of ADR symptoms with medication adherence and perceived quality of life (QoL). Patients and methods: Eighty-six adult, chronic-phase CML patients who had been on TKI treatment (79% on imatinib, 10.5% dasatinib, and 10.5% nilotinib) for at least 6 months participated in the study (mean age: 57.8 years, 52% males). The mean time from diagnosis was 5.1 years. All patients were interviewed, and patient-reported ADRs were obtained using a structured list. Adherence was assessed using Morisky’s 8-item Medication Adherence Scale (MMAS). The symptoms’ interference with patient’s daily QoL was measured by asking patients about the influence of symptom(s) on their mood, general condition, enjoyment of life, walking, relationships, and work. Results: Ninety-seven percent of the patients were suffering from at least one ADR. The mean number of different symptoms was seven (range: 0–15, median 6). The most commonly perceived ADRs were muscle soreness or cramp (69/86, 80%); swelling of hands, legs, feet, or around the eyes (59/86, 69%); and fatigue (43/86, 50%). No correlation was found between adherence and ADRs, because symptoms were equally common in each MMAS adherence class. Half of the patients felt that the ADRs had a negative influence on their daily QoL. A quarter of the patients reported that ADRs affected either their mood, general condition, or enjoyment of life. The incidence of almost all ADRs was much higher among patients reporting negative influence of ADRs on their daily life compared to total study population ( P =0.016). Conclusion: TKI-related ADRs were common among CML patients irrespective of patient’s adherence level. Patients who reported that ADRs had a negative influence on their daily QoL perceived more ADRs than those who did not experience a negative influence.
机译:目的:评估慢性髓样白血病(CML)患者在每次口服酪氨酸激酶抑制剂(TKI)治疗期间经历的不良药物反应(ADR),以及ADR症状与药物依从性和知觉生活质量(QoL)的相关性。患者和方法:接受TKI治疗的86位成人慢性期CML患者(伊马替尼79%,达沙替尼10.5%和尼罗替尼10.5%)接受了至少6个月的研究(平均年龄:57.8岁) ,男性占52%)。诊断的平均时间为5.1年。对所有患者进行了访谈,并使用结构化列表获得了患者报告的ADR。使用Morisky的8项药物治疗依从性量表(MMAS)评估依从性。通过询问患者症状对他们的情绪,总体状况,生活享受,行走,人际关系和工作的影响,来衡量症状对患者每日生活质量的干扰。结果:百分之九十七的患者患有至少一种ADR。不同症状的平均数为7(范围:0-15,中位数6)。最常见的ADR是肌肉酸痛或抽筋(69 / 86,80%);手,腿,脚或眼睛周围肿胀(59/86,69%);和疲劳(43 / 86,50%)。在依从性和ADR之间未发现相关性,因为在每个MMAS依从性类别中症状均相同。一半的患者认为ADR对他们的每日生活质量有负面影响。四分之一的患者报告说ADR影响了他们的情绪,总体状况或生活乐趣。与总研究人群相比,报告ADR对日常生活有负面影响的患者中几乎所有ADR的发生率都更高(P = 0.016)。结论:TML相关的ADR在CML患者中很常见,而与患者的依从程度无关。报告ADR对每日生活质量有负面影响的患者比没有受到负面影响的患者感知到更多的ADR。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号